AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
DOLUTEGRAVIR SODIUM; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE in Zimbabwe
1 product registered with MCAZ — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| SIROPIL TABLET, COATED; ORAL | 2025/7.13/6986 | EMCURE PHARMACEUTICALS LTD | active | 7 Jul 2030 |
DOLUTEGRAVIR SODIUM; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE — MCAZ Registration Details
MCAZ (Zimbabwe) has 1 registered product containing DOLUTEGRAVIR SODIUM; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE, of which 1 is currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track DOLUTEGRAVIR SODIUM; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.